Perfil epidemiológico de la afección por Covid-19 en pacientes con VIH/SIDA en Cochabamba, Bolivia
DOI:
https://doi.org/10.52428/20756208.v17i42.198Keywords:
COVID-19 epidemiology, HIV, epidemiological factors.Abstract
Summary: Covid-19 is a health problem, which mostly affects people with compromised immune systems, such as people living with HIV/AIDS (PLWHA). Objective: Describe the clinical impact that Covid-19 has had on PLWHA who attending at the Departmental Center for Surveillance, Information and Reference (CDVIR) of Cochabamba. Methods: A descriptive study was developed with a quantitative, retrospective approach, with the participation of 327 people living with HIV who attended a consultation between May and June 2021. It was carried out in two phases: in the first, I applied a questionnaire based on in the survey “Covid-19: Guidance and Survey Tool” designed by the Pan American Health Organization, and in the second phase the medical records of the patients were reviewed. Results: From the beginning of the Covid-19 epidemic until June 30, 2021, 34 of 318 PLWHA presented Covid-19 with confirmatory tests, with a cumulative incidence of 1.4%. Among the Covid-19 cases, only 4 patients (12%) reported moderate and severe symptoms. And only 29% felt affected in the provision of antiretroviral therapy (ARV), medical care and laboratories during quarantine. The factors related to the greater severity of Covid-19 were age, overweight, viral load (≥40 copies/ml), and CD4 (less than 500]. Conclusions: The progression of HIV / Covid-19 coinfection among PLWHA was similar to the general population, and the degree of impairment in access to health care services was relatively low.
Downloads
References
Worldometer. Total Coronavirus Cases in Bolivia (Internet); 2022. (Consultado 2022 May 12). Disponible en: https://www.worldometers.info/coronavirus/country/bolivia/
Defensoría del Pueblo. Informe Defensorial: “Evaluación de los servicios de tratamiento de las personas que viven con VIH/sida” (Internet); 2021; 1(1): 37-8. (consultado 2021 mayo 8). Disponible en: https://www.defensoria.gob.bo/uploads/files/evaluacion-de-los-servicios-de-tratamiento-de-las-personas-que-viven-con-vih-sida.pdf
Sustainable Development Solutions Network Bolivia. El VIH está incrementando en Bolivia, pero queda concentrado en pocos municipios (Internet); 2019 (Consultado 2021 abril 5). Disponible en: https://www.sdsnbolivia.org/el-vih-esta-incrementando-en-bolivia-pero-queda-concentrado-en-pocos municipios/#:~:text=La%20prevalencia%20del%20VIH%20ha,el%20primer%20trimestre%20de%202019
Karmen-Tuohy S, Carlucci PM, Zervou FN, et al. Outcomes among HIV-Positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2020; 85 (1): p. 6-10. Disponible en: https://doi.org/10.1097/QAI.0000000000002423
Martillo M, Bueno R. COVID-19 y VIH/SIDA: Implicaciones clínicas y epidemiológicas. 2020 (Pregrado). Jipijapa-Manabí-Ecuador. Disponible en: http://repositorio.unesum.edu.ec/bitstream/53000/2531/1/MARTILLO%20ALVAREZ%20MISHELL%20Y%20BUENO%20JIMENEZ%20RITA.pdf
Zhe X, Chao Z, Fu-Sheng W. Covid-19 en personas con VIH. The Lancet VIH. 2020; 7(8): p. 524-26. Disponible en: https://doi.org/10.1097/QAI.0000000000002423 DOI: https://doi.org/10.1097/QAI.0000000000002423
Chenneville T, Gabbidon K, Hanson P, et al. El impacto del Covid-19 en el tratamiento y la investigación del VIH: un llamado a la acción. Revista Internacional de investigación ambiental y salud pública. 2020; 17 (12). Disponible en: https://doi.org/10.3390/ijerph17124548 DOI: https://doi.org/10.3390/ijerph17124548
Solano-Ceh M, Coronado-García A, Velásquez-Paz A, et al. Factores de riesgo asociados a la mortalidad en pacientes con Covid-19 en el estado Oaxaca. Avances en Ciencias, Salud y Medicina. 2020; 7(4). Disponible en: https://www.oaxaca.gob.mx/salud/wp-content/uploads/sites/32/2021/05/Arti%CC%81culo_Factores-de-riesgo-COVID.pdf
Brown L, Spinelli M, Gandhi M. La interacción entre el VIH y el Covid-19: resumen de los datos y las respuestas hasta la fecha. Opinión actual sobre el VIH y el sida. 2021; 16(1): p.63-73. DOI: 10.1097 / COH.0000000000000659
Huang J, Xie N, Hu X, et al. Epidemiological, virological and serological features of Covid-19 cases in people living with HIV in Wuhan City: A population-based cohort study. Clinical infectious diseases. 2020. Disponible en: https://doi.org/10.1093/cid/ciaa1186 DOI: https://doi.org/10.1093/cid/ciaa1186
Cooper TJ, Woodward BL, Alom S, et al. Resultados de la enfermedad por coronavirus 2019 (Covid-19) en pacientes con VIH/SIDA: una revisión sistemática. Medicina Interna contra el VIH. 2020; 21(9): p.567-577. Disponible en: https://doi.org/10.1111/hiv.12911 DOI: https://doi.org/10.1111/hiv.12911
McMahon J, Hoy J, Kamarulzaman A, et al. Aprovechando los avances en VIH para Covid-19. The Lancet. 2020; 396(10256): p.943-44. Disponible en: https://doi.org/10.1016/S0140-6736(20)32012-2 DOI: https://doi.org/10.1016/S0140-6736(20)32012-2
Organización Panamericana de la Salud. Covid-19. Orientación y herramienta para hacer encuestas. 2020. Disponible en: https://iris.paho.org/handle/10665.2/53293
Etienne N, Karmochkine M, Slama L, et al. Infección por VIH y Covid-19: factores de riesgo de enfermedad grave. AIDS. 2020; 34(12): p.1771-774. Disponible en: https://doi.org/10.1097/QAD.0000000000002651 DOI: https://doi.org/10.1097/QAD.0000000000002651
Mirzael H, Mc Farland W, Karamouzian M, et al. Covid-19 entre personas que viven con el VIH: una revisión sistemática. AIDS. 2021; 25(1): 85-92. Disponible en: https://doi.org/10.1007/s10461-020-02983-2
Del Amo J, Polo R, Moreno S, et al. Incidencia y gravedad de Covid-19 en personas VIH positivas que reciben terapia antirretroviral: un estudio de cohorte. Annals of Internal Medicine. 2020; 173(7): p.536-41. Disponible en: https://doi.org/10.1007/s10461-020-02983-2 DOI: https://doi.org/10.1007/s10461-020-02983-2
Shiau S, Krause K, Valera P. La carga de Covid-19 en personas que viven con el VIH: una perspectiva sinémica. AIDS Behav. 2020; 24(8): p.2244-2249. Disponible en: https://doi.org/10.1007/s10461-020-02871-9 DOI: https://doi.org/10.1007/s10461-020-02871-9
Calza L, Bon I, Borderi M, et al. Resultados de Covid-19 en pacientes con infección por VIH no controlada. Revista de síndromes de inmunodeficiencia adquirida. 2021; 86(1): p.15-17. Disponible en: https://doi.org/10.1097/QAI.0000000000002537 DOI: https://doi.org/10.1097/QAI.0000000000002537
Adadi P, Kanwugu O. Vivir con el VIH en la época del Covid-19: un atisbo de esperanza. J Med Virol. 2020; 10. Disponible en: https://www.researchgate.net/profile/Parise-Adadi 2/publication/341915345_Living_with_HIV_in_the_time_of_COVID-19_a_glimpse_of_hope/links/5ed981dc299bf1c67d418e75/Living-with-HIV-in-the-time-of-COVID-19-a-glimpse-of-hope.pdf
Sun S, Hou J, Chen Y, et al. Desafíos para la atención del VIH y la salud psicológica durante la pandemia de Covid-19 entre las personas que viven con VIH en China. AIDS Behav. 2020. 24(10): p.2764-2765.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Liseth Arias López
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
